Fondazione Italiana Linfomi - ETS
3 clinical trials · 3 recruiting · OTHER
Trials by Fondazione Italiana Linfomi - ETS
RECRUITINGNCT05819528
Primary Cardiac Lymphoma: Italian Multicenter Experience
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on unanswered...
Sponsor: Fondazione Italiana Linfomi - ETSEnrolling: 4317 locations
Primary Cardiac Lymphoma
RECRUITINGPhase 2NCT06835530
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells...
Prospective, multicenter, single arm, phase II study, to evaluate the efficacy of the combination rituximab-golcadomide as a chemo free approach in a population of older patients...
Sponsor: Fondazione Italiana Linfomi - ETSEnrolling: 4720 locations
Diffuse Large B Cell Non-Hodgkin Lymphoma
RECRUITINGNCT06588205
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell...
This is a observational, retrospective and prospective study designed to assess the potential correlations between MYC alterations, lymphoma mutational landscape and functional...
Sponsor: Fondazione Italiana Linfomi - ETSEnrolling: 20020 locations
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements